1-Dehydro-[10]-gingerdione has potential for research in NF-κB-related inflammatory and autoimmune diseases; it inhibits LPS-induced NF-κB transcriptional activity and directly suppresses IKKβ activity by targeting the activation loop of IKKβ, thereby disrupting IKKβ-catalyzed IκBα phosphorylation in agonist-stimulated macrophages.